cyclohexanol has been researched along with nitrophenols in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FLEMING, WJ; MEYERS, DB; ROWE, EJ | 1 |
| Björklund, E; Fowler, CJ; Nilsson, J; Norén, E | 1 |
| Clarke, G; Clarke, N; Cryan, JF; Desbonnet, L; Dinan, TG; Gogos, JA; Karayiorgou, M; O'Leary, C; O'Tuathaigh, CM; Petit, E; Tighe, O; Waddington, JL; Walsh, J | 1 |
3 other study(ies) available for cyclohexanol and nitrophenols
| Article | Year |
|---|---|
A comparison of the pharmacological properties of two nitrated cyclohexanols.
Topics: Cyclohexanols; Nitrates; Nitrogen Oxides; Nitrophenols | 1958 |
Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays.
Topics: Animals; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Modulators; Chromans; Cyclohexanols; Dopamine; Enzyme Assays; Glycerides; Humans; Monoacylglycerol Lipases; Nitrophenols; Piperidines; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thiazolidinediones; Troglitazone | 2010 |
Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes.
Topics: Alleles; Animals; Anxiety; Benzophenones; Benzoxazines; Biogenic Monoamines; Cannabinoid Receptor Agonists; Cannabinoids; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Cyclohexanols; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Nitrophenols; Pain Measurement; Phenotype; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Social Behavior; Swimming; Tolcapone | 2012 |